Back to search
Heart Failure - NYHA II - IV
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Heart Failure - NYHA II - IV trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Heart Failure - NYHA II - IV trials you may qualify forPEDAL-HF is a registry-based randomized prospective multicenter study. The investigators plan to include 1000 patients who were recently admitted with acute dec…
This study will compare two different methods to pace the heart to treat heart failure including: 1. The current standard method of implanting a pacing lead in…
This study is open to adults with chronic heart failure (HF) who have a reduced left ventricular ejection fraction (LVEF) of less than 40%. People can join the…
This study is open to adults aged 18 or above legal age with heart failure. People can join the study if they have heart failure symptoms and a left ventricular…
The goal of this clinical trial is to learn if increasing the dose of diuretics to achieve a higher urine sodium target produces better clinical results when tr…
Heart failure is a severe heart disease, where the heart's ability to pump blood is unsatisfactory. The consequence is a high risk of hospitalization and death.…
The study aims to test the diagnostic accuracy of T1 mapping for the diagnosis of cardiac amyloidosis prospectively. The hypothesis is that T1 mapping in older…
Using the MOST framework, factorial pilot design, and an iterative, community-based process, the purpose of this study is to pilot test to further develop and r…
Heart Failure (HF) is a complex disease associated with the highest burden of cost to the healthcare system. The cardiopulmonary exercise test (CPET) is instrum…